Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

BioNTech (BNTX) stock tumbles 17% after reporting Q4 losses, missing 2026 revenue projections, and announcing co-founder departures. Full analysis here.

The German biotech provides a weak full-year outlook and announces the exit of its co-founders.

Detailed price information for Exxon Mobil Corp (XOM-N) from The Globe and Mail including charting and trades.

BioNTech (NASDAQ:BNTX) management outlined a strategy centered on late-stage oncology execution and combination-based development during the company’s fourth-quarter and full-year 2025 earnings call, ...

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...